Overview

Improving Pain Management After Total Shoulder Replacement Using Bupivacaine Liposome

Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
To improve pain control and decrease opioid requirements for subjects undergoing Total Shoulder Replacement.
Phase:
Phase 4
Details
Lead Sponsor:
University of Massachusetts, Worcester
Treatments:
Acetaminophen
Bupivacaine
Epinephrine
Epinephryl borate
Gabapentin
Oxycodone
Racepinephrine